Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Highly Accessed Email this article to a friend

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients

Chamaida Plasencia*, Dora Pascual-Salcedo, Sara García-Carazo, Leticia Lojo, Laura Nuño, Alejandro Villalba, Diana Peiteado, Florencia Arribas, Jesus Díez, Maria Teresa López-Casla, Emilio Martín-Mola and Alejandro Balsa

Arthritis Research & Therapy 2013, 15:R79  doi:10.1186/ar4258

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?